Robert J. Adelman, Director, 10% Owner at ARYx Therapeutics, Inc. (ARYX), bought 623,399 shares at $10.00 ($3.0M) on 2007-11-13, disclosed to the SEC on 2007-11-14.
Open-market purchase of $3.0M ARYX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 323,399 | $0 | 0.0% |
| 2 | $10.00 | 300,000 | $3.0M | 100.0% |
| Total | $4.81 avg | 623,399 | $3.0M | 100% |
| Filing → |
| AKRO | SELL | 2020-03-03 | $731K | — | Filing → |
| AKRO | SELL | 2020-01-06 | $1.4M | — | Filing → |